California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on May 4, 2026

May 4, 2026

Curated Digital Health Works; Now There’s a Claims Study to Prove It

Indeterminate GlobeNewswire

May 4, 2026

BioMogging Brings Research-Backed Rigour to Looksmaxxing as the Discipline Goes Mainstream

Indeterminate GlobeNewswire

May 4, 2026

Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform

Indeterminate GlobeNewswire

May 4, 2026

Brainway Launches Personalized Anti-Procrastination App Grounded in CBT, Earns 6,000+ User Reviews

Indeterminate GlobeNewswire

May 4, 2026

Sienna Continues Platform Growth

Indeterminate GlobeNewswire

May 4, 2026

Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs

Indeterminate GlobeNewswire

May 4, 2026

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

Indeterminate GlobeNewswire

May 4, 2026

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Indeterminate GlobeNewswire

May 4, 2026

NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

Indeterminate GlobeNewswire

May 4, 2026

Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

Indeterminate GlobeNewswire

May 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

May 4, 2026

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

May 4, 2026

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Indeterminate GlobeNewswire

May 4, 2026

Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1

Indeterminate GlobeNewswire

May 4, 2026

Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD

Indeterminate GlobeNewswire

May 4, 2026

Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems

Indeterminate GlobeNewswire

May 4, 2026

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton

Indeterminate GlobeNewswire

May 4, 2026

Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

May 4, 2026

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

Indeterminate GlobeNewswire

May 4, 2026

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

Indeterminate GlobeNewswire